Quantcast

Disease and Therapy Review of Senile Dementia

November 13, 2008

Research and Markets (http://www.researchandmarkets.com/research/ef4799/disease_and_therap) has announced the addition of the “Disease and Therapy Review: Senile Dementia” report to their offering.

The Senile Dementia Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis and dementia types, and an overview of treatments. Dosing information and treatment costs are provided for Aricept, Namenda, Razadyne, and Exelon. General sales information is also included for these four products. Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by a senior market research team. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Langes Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

Key Topics Covered:

– OVERVIEW

– INCIDENCE AND PREVALENCE

– DIAGNOSIS

– TREATMENT

– DOSING

– TREATMENT COSTS

– MARKET SIZE

– REFERENCES/RESOURCES

For more information visit http://www.researchandmarkets.com/research/ef4799/disease_and_therap.




comments powered by Disqus